Prometastatic NOTCH signaling in colon cancer

Cancer Discovery

Volumn 5, Issue 2, 2015, Pages 115-117

  Kranenburg, Onno ^a  

^a UNIVERSITY MEDICAL CENTER UTRECHT   (Netherlands)

Author keywords

[No Author keywords available]

Indexed keywords

ABELSON KINASE; ADAM PROTEIN; DELTA LIKE LIGAND; HISTONE DEACETYLASE 4; IMATINIB; JAGGED1; LIGAND; NOTCH RECEPTOR; PLATELET DERIVED GROWTH FACTOR RECEPTOR; PROTEIN P53; PROTEIN TYROSINE KINASE; RHO KINASE; UNCLASSIFIED DRUG; PROTEIN SERINE THREONINE KINASE; RHO GUANINE NUCLEOTIDE EXCHANGE FACTOR;

ARTICLE; CELL DIFFERENTIATION; CELL PROLIFERATION; CELL SURVIVAL; COLORECTAL CANCER; DAB1 GENE; DRUG TARGETING; EPITHELIAL MESENCHYMAL TRANSITION; GENE; HUMAN; INTRACELLULAR SIGNALING; METASTATIS; MOLECULAR TYPING; NONHUMAN; ONCOGENE MYC; PROTEIN DOMAIN; PROTEIN EXPRESSION; SECRETORY CELL; STROMA CELL; TUMOR CELL; TUMOR INVASION; ANIMAL; COLORECTAL TUMOR; METABOLISM; PATHOLOGY;

ANIMALS; COLORECTAL NEOPLASMS; HUMANS; PROTEIN-SERINE-THREONINE KINASES; RECEPTORS, NOTCH; RHO GUANINE NUCLEOTIDE EXCHANGE FACTORS;

EID: 84922345012     PISSN: 21598274     EISSN: 21598290     Source Type: Journal    
DOI: 10.1158/2159-8290.CD-14-1456     Document Type: Article

References (11)

1. Sonoshita M, Itatani Y, Kakizaki F, Sakimura K, Terashima T, Katsuyama Y, et al. Promotion of colorectal cancer invasion and metastasis through activation of NOTCH-DAB1-ABL-RHOGEF protein TRIO. Cancer Discov 2015;5: 198-211.
2. Sonoshita M, Aoki M, Fuwa H, Aoki K, Hosogi H, Sakai Y, et al. Suppression of colon cancer metastasis by Aes through inhibition of Notch signaling. Cancer Cell 2011; 19: 125-37.
3. Lu J, Ye X, Fan F, Xia L, Bhattacharya R, Bellister S, et al. Endothelial cells promote the colorectal cancer stem cell phenotype through a soluble form of Jagged-1. Cancer Cell 2013; 23: 171-85.
4. Ntziachristos P, Lim JS, Sage J, Aifantis I. From fly wings to targeted cancer therapies: a centennial for notch signaling. Cancer Cell 2014; 25: 318-34.
5. Kitadai Y, Sasaki T, Kuwai T, Nakamura T, Bucana CD, Fidler IJ. Targeting the expression of platelet-derived growth factor receptor by reactive stroma inhibits growth and metastasis of human colon carcinoma. Am J Pathol 2006; 169: 2054-65.
6. Chanrion M, Kuperstein I, Barriere C, El Marjou F, Cohen D, Vignjevic D, et al. Concomitant Notch activation and p53 deletion trigger epithelial-to-mesenchymal transition and metastasis in mouse gut. Nat Commun 2014; 5: 5005.
7. Dienstmann R, Guinney J, Delorenzi M, De Reynies A, Roepman P, Sadanandam A, et al. Colorectal Cancer Subtyping Consortium (CRCSC) identification of a consensus of molecular subtypes. J Clin Oncol 32:5s, 2014 (suppl; abstr 3511).
8. Reffay M, Parrini MC, Cochet-Escartin O, Ladoux B, Buguin A, Coscoy S, et al. Interplay of RhoA and mechanical forces in collective cell migration driven by leader cells. Nat Cell Biol 2014; 16: 217- 23.
9. Ritsma L, Steller EJ, Beerling E, Loomans CJ, Zomer A, Gerlach C, et al. Intravital microscopy through an abdominal imaging window reveals a pre-micrometastasis stage during liver metastasis. Sci Transl Med 2012; 4: 158ra45.
10. Hoehler T, von Wichert G, Schimanski C, Kanzler S, Moehler MH, Hinke A, et al. Phase I/II trial of capecitabine and oxaliplatin in combination with bevacizumab and imatinib in patients with metastatic colorectal cancer: AIO KRK 0205. Br J Cancer 2013; 109: 1408-13.
11. Michael M, Zalcberg J, Gibbs P, Lipton L, Gouillou M, Jefford M, et al. A phase I trial of imatinib in combination with mFOLFOX6- bevacizumab in patients with advanced colorectal cancer. Cancer Chemother Pharmacol 2013; 71: 321-30.